Geniposide alleviates lipopolysaccharide-caused apoptosis of murine kidney podocytes by activating Ras/Raf/MEK/ERK-mediated cell autophagy

References

• Kodner C. Diagnosis and management of nephrotic syndrome in adults. Am Fam Physician. 2016;93:479–485.
   PubMed Web of Science ®Google Scholar
• Al-Azzawi HF, Obi OC, Safi J, et al. Nephrotic syndrome-induced thromboembolism in adults. Int J Crit Illn Inj Sci. 2016;6:85.
   PubMedGoogle Scholar
• Seeger H, Fehr T. Nephrotic syndrome in adult patients–etiology and complications. Praxis. 2016;105:259–267.
   PubMedGoogle Scholar
• Rheault MN, Gbadegesin RA. The genetics of nephrotic syndrome. J Pediatr Genet. 2016;5:15–24.
   PubMed Web of Science ®Google Scholar
• Inoue K, Ishibe S. Podocyte endocytosis in the regulation of the glomerular filtration barrier. Am J Physiol Renal Physiol. 2015;309:F398–F405.
   PubMed Web of Science ®Google Scholar
• Lewko B. Treatment of nephrotic syndrome: immuno- or rather podocyte therapy? Postepy Hig Med Dosw. 2016;70:459–470.
   Web of Science ®Google Scholar
• Qi Q, Mao Y, Tian Y, et al. Geniposide inhibited endothelial-mesenchymal transition via the mTOR signaling pathway in a bleomycin-induced scleroderma mouse model. Am J Translation Res. 2017;9:1025–1036.
   PubMed Web of Science ®Google Scholar
• Shan M, Yu S, Yan H, et al. A review on the phytochemistry, pharmacology, pharmacokinetics and toxicology of geniposide, a natural product. Molecules (Basel, Switzerland). 2017;22:1689.
   PubMed Web of Science ®Google Scholar
• Huang B, Chen P, Huang L, et al. Geniposide attenuates post-ischaemic neurovascular damage via GluN2A/AKT/ERK-dependent mechanism. Cell Physiol Biochem. 2017;43:705–716.
   PubMed Web of Science ®Google Scholar
• Rong YP, Huang HT, Liu JS, et al. Protective effects of geniposide on hepatic ischemia/reperfusion injury. Transplant Proc. 2017;49:1455–1460.
   PubMed Web of Science ®Google Scholar
• Yu B, Shen Y, Qiao J, et al. Geniposide attenuates Staphylococcus aureus-induced pneumonia in mice by inhibiting NF-kappaB activation. Microbial Pathogen. 2017;112:117–121.
   PubMed Web of Science ®Google Scholar
• Liu J, Yin F, Zheng X, et al. Geniposide, a novel agonist for GLP-1 receptor, prevents PC12 cells from oxidative damage via MAP kinase pathway. Neurochem Int. 2007;51:361–369.
   PubMed Web of Science ®Google Scholar
• Huang H, Zhang X, Huang Z, et al. Geniposide reverses multidrug resistance in vitro and in vivo by inhibiting the efflux function and expression of P-glycoprotein. Exper Therap Med. 2017;13:437–442.
   PubMed Web of Science ®Google Scholar
• Deng Y, Guan M, Xie X, et al. Geniposide inhibits airway inflammation and hyperresponsiveness in a mouse model of asthma. Int Immunopharmacol. 2013;17:561–567.
   PubMed Web of Science ®Google Scholar
• Zhang Y, Ding Y, Zhong X, et al. Geniposide acutely stimulates insulin secretion in pancreatic beta-cells by regulating GLP-1 receptor/cAMP signaling and ion channels. Mol Cell Endocrinol. 2016;430:89–96.
   PubMed Web of Science ®Google Scholar
• Wu W, Yang JJ, Wan YG, et al. Pathogenesis and treatment of insulin resistance in chronic kidney disease and interventional effects of Chinese herbal medicine. China J Chinese Materia Medica. 2017;42:49–55.
   Google Scholar
• Boitsova EB, Morgun AV, Osipova ED, et al. The inhibitory effect of LPS on the expression of GPR81 lactate receptor in blood-brain barrier model in vitro. J Neuroinflamm. 2018;15:196.
   PubMed Web of Science ®Google Scholar
• Hsu MF, Bettaieb A, Ito Y, et al. Protein tyrosine phosphatase Shp2 deficiency in podocytes attenuates lipopolysaccharide-induced proteinuria. Scientific Rep. 2017;7:461.
   PubMed Web of Science ®Google Scholar
• He P, Kawamura H, Takemoto M, et al. Combination of cilostazol and probucol protected podocytes from lipopolysaccharide-induced injury by both anti-inflammatory and anti-oxidative mechanisms. J Nephrol. 2017;30:531–541.
   PubMed Web of Science ®Google Scholar
• Zhou Y, Wu D, Tao J, et al. MicroRNA-133 inhibits cell proliferation, migration and invasion by targeting epidermal growth factor receptor and its downstream effector proteins in bladder cancer. Scand J Urol. 2013;47:423–432.
   PubMed Web of Science ®Google Scholar
• Shi Z, Wu D, Yao JP, et al. Protection against oxygen-glucose deprivation/reperfusion injury in cortical neurons by combining omega-3 polyunsaturated acid with lyciumbarbarum polysaccharide. Nutrients. 2016;8:41.
   PubMed Web of Science ®Google Scholar
• Hickey TE, Majam G, Guerry P. Intracellular survival of Campylobacter jejuni in human monocytic cells and induction of apoptotic death by cytholethal distending toxin. Infect Immun. 2005;73:5194–5197.
   PubMed Web of Science ®Google Scholar
• Li R, Yin F, Guo YY, et al. Knockdown of ANRIL aggravates H2O2-induced injury in PC-12 cells by targeting microRNA-125a. Biomed Pharmacother. 2017;92:952–961.
   PubMed Web of Science ®Google Scholar
• Ouyang L, Chen Y, Wang XY, et al. Polygonatum odoratum lectin induces apoptosis and autophagy via targeting EGFR-mediated Ras-Raf-MEK-ERK pathway in human MCF-7 breast cancer cells. Phytomed: Int J Phytother Phytopharmacol. 2014;21:1658–1665.
   PubMed Web of Science ®Google Scholar
• Raij L, Tian R, Wong JS, et al. Podocyte injury: the role of proteinuria, urinary plasminogen, and oxidative stress. Am J Physiol Renal Physiol. 2016;311:F1308–f1317.
   PubMed Web of Science ®Google Scholar
• Wada T, Pippin JW, Marshall CB, et al. Dexamethasone prevents podocyte apoptosis induced by puromycin aminonucleoside: role of p53 and Bcl-2-related family proteins. JASN. 2005;16:2615–2625.
   Web of Science ®Google Scholar
• Menini S, Iacobini C, Oddi G, et al. Increased glomerular cell (podocyte) apoptosis in rats with streptozotocin-induced diabetes mellitus: role in the development of diabetic glomerular disease. Diabetologia. 2007;50:2591–2599.
   PubMed Web of Science ®Google Scholar
• Booth LA, Tavallai S, Hamed HA, et al. The role of cell signalling in the crosstalk between autophagy and apoptosis. Cellular Signalling. 2014;26:549–555.
   PubMed Web of Science ®Google Scholar
• Yadav A, Vallabu S, Arora S, et al. ANG II promotes autophagy in podocytes. Am J Physiol Cell Physiol. 2010;299:C488–C496.
   PubMed Web of Science ®Google Scholar
• Tan X, Chen Y, Liang X, et al. Lipopolysaccharide-induced podocyte injury is mediated by suppression of autophagy. Mol Med Rep. 2016;14:811–818.
   PubMed Web of Science ®Google Scholar
• Shin JH, Bae DJ, Kim ES, et al. Autophagy regulates formation of primary Cilia in mefloquine-treated cells. Biomol Therap. 2015;23:327–332.
   PubMed Web of Science ®Google Scholar
• Lee JS, Lee GM. Rapamycin treatment inhibits CHO cell death in a serum-free suspension culture by autophagy induction. Biotechnol Bioeng. 2012;109:3093–3102.
   PubMed Web of Science ®Google Scholar
• Wang J. Beclin 1 bridges autophagy, apoptosis and differentiation. Autophagy. 2008;4:947–948.
   PubMed Web of Science ®Google Scholar
• Sooro MA, Zhang N, Zhang P. Targeting EGFR-mediated autophagy as a potential strategy for cancer therapy. Int J Canc. 2018;143:2116–2125.
   PubMed Web of Science ®Google Scholar
• McCubrey JA, Steelman LS, Chappell WH, et al. Roles of the Raf/MEK/ERK pathway in cell growth, malignant transformation and drug resistance. Biochimica et Biophysica Acta. 2007;1773:1263–1284.
   PubMed Web of Science ®Google Scholar
• Corcelle E, Nebout M, Bekri S, et al. Disruption of autophagy at the maturation step by the carcinogen lindane is associated with the sustained mitogen-activated protein kinase/extracellular signal-regulated kinase activity. Cancer Res. 2006;66:6861–6870.
   PubMed Web of Science ®Google Scholar